Trial · NCT00689052
Outcomes13
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 13 of 13
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | The Change in the Weekly Mean of the 24-hour Average Pain Score From a Daily Diary as Measured by the 11-point Likert Pain Scale | Baseline and Week 29 | FAS (All randomized and treated patients with a baseline and at least one post-baseline will be included in the Full Analysis Set (FAS)) | ||
| SECONDARY | The Proportion of Patients Very Much Improved or Much Improved on the Patient's Global Impression of Improvement (PGI-I) 7-point Scale | Week 29 (at the end of the maintenance phase) | FAS (All randomized and treated patients with a baseline and at least one post-baseline will be included in the Full Analysis Set (FAS)) | ||
| SECONDARY | The Short Form 36 (SF-36) Health Survey, Physical Functioning Subscale (Change From Baseline). | Baseline and Week 29 | FAS (All randomized and treated patients with a baseline and at least one post-baseline will be included in the Full Analysis Set (FAS)) | ||
| SECONDARY | The Proportion of Patients With at Least a 30% or at Least a 50% Improvement Relative to Baseline in Pain (Assessed on the 11-point Likert Pain Scale | Baseline and Week 29 | FAS (All randomized and treated patients with a baseline and at least one post-baseline will be included in the Full Analysis Set (FAS)) | ||
| SECONDARY | Fibromyalgia Impact Questionnaire (FIQ) Total Score (Change From Baseline) | Baseline and Week 29 | FAS (All randomized and treated patients with a baseline and at least one post-baseline will be included in the Full Analysis Set (FAS)) | ||
| SECONDARY | Hospital Anxiety and Depression Scale (HADS) (Change From Baseline). | Baseline and Week 29 | FAS (All randomized and treated patients with a baseline and at least one post-baseline will be included in the Full Analysis Set (FAS)) | ||
| SECONDARY | The Short Form 36 (SF-36) Health Survey (Change From Baseline) (Excluding the Physical Functioning Subscale(PF)). | Baseline and Week 29 | FAS (All randomized and treated patients with a baseline and at least one post-baseline will be included in the Full Analysis Set (FAS)) | ||
| SECONDARY | Euroqol- 5 Dimensions (EQ-5D) Survey (Change From Baseline) | Baseline and Week 29 | FAS (All randomized and treated patients with a baseline and at least one post-baseline will be included in the Full Analysis Set (FAS)) | ||
| SECONDARY | Multidimensional Assessment of Fatigue (MAF) Index (Change From Baseline) | Baseline and Week 29 | FAS (All randomized and treated patients with a baseline and at least one post-baseline will be included in the Full Analysis Set (FAS)) | ||
| SECONDARY | Medical Outcomes Study (MOS) Sleep Scale (Change From Baseline) | Baseline and Week 29 | FAS (All randomized and treated patients with a baseline and at least one post-baseline will be included in the Full Analysis Set (FAS)) | ||
| SECONDARY | Clinical Global Impression of Severity (CGI-S Scores) | Baseline and Week 29 | FAS (All randomized and treated patients with a baseline and at least one post-baseline will be included in the Full Analysis Set (FAS)) | ||
| SECONDARY | Frequency of Rescue Medication for Pain | Week 29 | FAS (All randomized and treated patients with a baseline and at least one post-baseline will be included in the Full Analysis Set (FAS)) | ||
| SECONDARY | Change From Baseline in Mean Tender Point Threshold | Baseline and Week 29 | FAS (All randomized and treated patients with a baseline and at least one post-baseline will be included in the Full Analysis Set (FAS)) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00689052/outcomes